Market Overview The US Adrenocortical Carcinoma Treatment Market depends heavily on clinical trial infrastructure given the rarity limiting randomized evidence generation. The US Adrenocortical Carcinoma Treatment Market is anticipated to grow through 2030, supported by cooperative group networks, basket trial designs, real-world evidence programs, compassionate use pathways, biomarker-adaptive...